Carisma Therapeutics has gone public, entered a broad collaboration with Moderna, and ceased development of its original ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

We live in a time of hope for millions around the world, as technological advancements and research breakthroughs hold the ...

Configurable FlexFactory™ biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities—all within the same space. Plan ...